Gemini bioproducts:1110293 [16-003546]
Ended Awarded
- Contract number
- HHSN26400002
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,925
Award facts
- Contract value 100% obligated
- $9,925.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Broderick, CA 95605, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health, to Gemini Bioproducts LLC for the procurement of cell culture products and related scientific reagents. The contract, awarded on May 4, 2016, carries a ceiling value of $9,925.00 with a firm fixed-price structure and was designated as a Total Small Business set-aside. The work is to be performed at Gemini Bioproducts' facility in West Sacramento, California, with an ultimate completion date of May 31, 2016. As a BPA call, this award draws from an existing indefinite delivery/indefinite quantity agreement established to streamline procurement of critical biological supplies for federal research institutions.
Gemini Bioproducts LLC, a registered small business supplier since 2001, specializes in manufacturing and distributing cell culture media, fetal bovine serum, and specialized scientific reagents essential to biomedical research. The company maintains a strong track record of supporting NIH agencies and federal research initiatives, with demonstrated expertise in delivering high-quality biological products that support infectious disease research and other scientific endeavors. This contract reflects NIAMS' reliance on Gemini Bioproducts' capabilities to provide reliable supply of critical reagents necessary for the Institute's research mission focused on arthritis, musculoskeletal diseases, and skin conditions.
Quick answers
Who was awarded contract HHSN26400002?
HHSN26400002 was awarded to Gemini Bioproducts LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on May 4, 2016.
How much is contract HHSN26400002 worth?
The government has obligated $9,925 on HHSN26400002.
Is contract HHSN26400002 an order under another contract?
Yes. HHSN26400002 is a BPA call under HHSN263201500189B, a blanket purchase agreement.
Was contract HHSN26400002 competed?
The extent of competition for HHSN26400002 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award